|
|||||||||||
 |
|||||||||||
|
|||||||||||
Top Stories
Immunize.org Website and Clinical Resources
Vaccine Information Statements
Featured Resources
Notable Publications
Upcoming Events
FDA licenses Moderna's next generation mRNA COVID-19 Vaccine (mNexspike) for people age 12 to 64 years with high-risk conditions and all adults age 65 and older. ACIP will consider recommendations for its use at its June meeting.
On May 30, FDA licensed mNexspike (Moderna) to prevent COVID-19 disease in adults age 65 years and older as well as those age 12 through 64 years with at least one underlying condition that elevates their risk for severe outcomes from COVID-19. Among other differences, a dose of mNexspike contains 10 mcg of messenger RNA, compared to 50 mcg in Moderna’s Spikevax messenger RNA vaccine.
Immunize.org updates “Vaccine Administration Record for Children and Teens” and “Vaccine Administration Record for Adults”
Immunize.org updated vaccine administration records for children and teens and for adults, adding Penmenvy (MenABCWY, GSK), which was licensed on February 14, 2025. ACIP voted on recommendations for its use at the April meeting; these recommendations are pending acceptance by the CDC Director or Secretary of Health.
Related Links
Immunize.org continues to update its standing orders templates to remove the reference to the excipient table that used to appear in Appendix B of the Epidemiology and Prevention of Vaccine-Preventable Diseases (the "Pink Book"). The two updated standing order templates posted in the past week are:
 Previously announced updated standing orders templates include:
Related Links
Immunize.org updated its Notification of Immunization Letter Template, adding Penmenvy (MenABCWY, GSK), which was licensed on February 14, 2025. ACIP voted on recommendations for its use at the April meeting; these recommendations are pending acceptance by the CDC Director or Secretary of Health. Related Links
For National Men’s Health Week, June 9–15, encourage men to seek preventive care, including vaccination. Happy Father’s Day! National Men's Health Week is June 9–15, ending on Father's Day. This annual observance encourages men of all ages to prioritize their health and seek preventive care including recommended vaccines. Compared with women, men generally die earlier, become ill at a younger age, and develop more chronic illnesses, but are up to 50% less likely to seek medical care. According to CDC, more than 14% of adult men are in fair or poor health.
As of June 5, CDC reported 1,168 confirmed measles cases in 2025 in 33 states, including the first case reported this year in South Dakota. This case occurred in an adult resident of Meade County who became ill after international travel. The states with the most confirmed cases in 2025 are Texas (742, 63.5%) and Kansas (71, 6.1%). Among confirmed cases, 12% were hospitalized and two out of three were younger than age 20 years.
Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a recent citation. These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Spotlight on the website: "Ask the Experts" topics and subtopics
This week, we continue highlighting our popular “Ask the Experts” section. This resource provides more than 1,300 practical answers to questions from healthcare professionals about vaccines and vaccine administration. Content is divided into two categories:
IZ Express regularly provides readers with information about Immunize.org’s new and updated educational materials for healthcare professionals and handouts for patients. All Immunize.org materials are free to distribute.
Immunize.org recently updated its clinical resource titled Administering Vaccines: Dose, Route, Site, and Needle Size to add Penmenvy, the new MenABCWY vaccine from GSK. Summary: Spanish and Pohnpeian VIS translations released in April and May
IZ Express provides readers with information about new and updated VISs, translations, and resources. In April, Immunize.org provided updated Spanish translations (PDF and RTF for electronic medical record systems). In May, the Cerro Gordo County Public Health Department generously donated 16 new Pohnpeian VIS translations to post on the website. Immunize.org offers three clinical resources that link to VISs via QR codes:
On May 29, CDC released updated VISs for pneumococcal polysaccharide vaccine (PPSV23) and pneumococcal conjugate vaccine (PCV). Changes incorporate recommendations for the routine use of PCV for adults age 50 years and older (previously 65 years) and the limited use of PPSV23. The updated VISs refer to PCVs generally and no longer reference specific PCV products. Vaccinate adults! Order laminated 2025 U.S. adult immunization schedule booklets.
Laminated booklets of the 2025 U.S. adult immunization schedule are still available in the Immunize.org shop. The 2025 child and adolescent schedule booklets sold out.  Adult Booklets 1 copy: $10.00 2–4 copies: $9.50 each 5–19 copies: $8.50 each 20–99 copies: $7.50 each 100–499 copies: $6.00 each 500–999 copies: $5.00 each 1,000–1,999 copies: $4.00 each 2,000+ copies: $3.25 each Visit the Shop Immunize.org: Laminated Schedules web page to view images and order today! For additional information, call 651-647-9009 or email [email protected]. Related Links
Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Immunize.org offers a social media program to highlight our educational resources for a new audience of vaccinators. Our social media channels now feature our most popular printable resources and Ask the Experts questions, as well as announcements important to frontline vaccinators. Please view and share our newest feature, the Ask the Experts Video Series. Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
"Trends in County-Level MMR Vaccination Coverage in Children in the United States" published in JAMA
In the June 2 issue, JAMA published Trends in County-Level MMR Vaccination Coverage in Children in the United States. Parts of the research letter appear below. Virtual: Register for Immunize.org Website Office Hours. Ask questions and learn about our "News & Updates" web section on June 11 at 4:00 p.m. (ET) or June 12 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, June 11 at 4:00 p.m. (ET) or Thursday, June 12 at 12:00 p.m. (ET). The same content will be covered in both sessions. Register today for Immunize.org Website Office Hours (content is the same for both): Th archive of previous Website Office Hours content is posted at Immunize.org’s "Webinars & Videos" page. These archived programs include Ask the Experts; Clinical Resources; Vaccine Information Statements (VISs); Affiliated Websites; Images, Webinars, Videos, & Social Media; Official Guidance; Publication Archives, Vaccine Timeline, & About Us; Travel Vaccines, Vaccine Confidence, & Addressing Concerns; and Vaccines A–Z. Virtual: AIM hosts webinar, “Responding to Measles Outbreaks in High Priority Populations Part II,” on June 17 at 2:00 p.m. (ET)
The Association of Immunization Managers (AIM) will present a 1-hour webinar titled Responding to Measles Outbreaks in High Priority Populations Part II beginning at 2:00 p.m. (ET) on June 17. Based on feedback from Part I, this webinar will focus on strategies and engagement with close-knit communities. Virtual: NFID hosts webinar, “Protecting Patients Before Travel,” on June 18 at 1:00 p.m. (ET); CE credit offered
NFID will host a webinar titled Protecting Patients Before Travel at 1:00 p.m. (ET) on June 18. The panel includes NFID Medical Director Robert H. Hopkins Jr., MD; Chapman University School of Pharmacy Professor Jeffery A. Goad, PharmD, MPH; and ACIP member and Harvard Medical School Associate Professor Lin H. Chen, MD. Speakers will review current recommendations for travelers and share implementation strategies. Virtual: Watch June 25–27 ACIP meeting with discussion of several vaccine recommendations, including COVID-19, HPV, influenza, meningococcal, and RSV
CDC has been scheduled to convene the ACIP on June 25–27. Recommendation votes are scheduled for COVID-19, HPV, influenza, meningococcal, and RSV vaccines. Additionally, the agenda includes discussion of vaccines targeting anthrax, chikungunya, cytomegalovirus (CMV), Lyme, and pneumococcal diseases.
For more upcoming events, visit our Calendar of Events. |
|||||||||||
|
